The Challenge of Antimicrobial Resistance: New Regulatory Tools to Support Product Development

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|2|166-168

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.2, 2014-08, pp. : 166-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a cell-based medicinal product: regulatory structures in the European Union

By Gálvez Patricia   Clares Beatriz   Hmadcha Abdelkrim   Ruiz Adolfina   Soria Bernat  

British Medical Bulletin, Vol. 105, Iss. 1, 2013-03 ,pp. : 85-105

Oxford University Press

Access to resources Recommend Favorite

Heteroresistance of opportunistic bacteria to antimicrobial peptides: a new challenge to antimicrobial therapy of cystic fibrosis infections

By El-Halfawy Omar M   Valvano Miguel A  

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 591-595

Future Medicine

Access to resources Recommend Favorite

What’s new in antimicrobial use and resistance in critically ill patients?

By Bassetti Matteo   Nicolau David   Calandra Thierry  

Intensive Care Medicine, Vol. 40, Iss. 3, 2014-03 ,pp. : 422-426

Springer Publishing Company

Access to resources Recommend Favorite

Impetigo: A need for new therapies in a world of increasing antimicrobial resistance

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 150-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis

By Martin T.   Sims N.   Ng K.  

Osteoporosis International, Vol. 19, Iss. 8, 2008-08 ,pp. : 1125-1138

Springer Publishing Company

Access to resources Recommend Favorite